Jaffer Ajani

Jaffer Ajani is a high senior professor at The University of Texas MD Anderson Cancer Center. His research focuses on gastrointestinal oncology, specifically esophageal and gastric cancer, with an emphasis on tumor-stromal-immune interactions, peritoneal metastasis, and organ preservation. His recent work investigates the Hippo/YAP1 pathway, TIM3+ tumor-associated macrophages, and KMT2D loss in gastric cancer progression, alongside blood levels of forever plastics and lung cancer mortality. He has received major grants for developing novel therapeutic strategies for peritoneal metastases from gastric adenocarcinoma and for targeting intertwined RhoA and YAP1 pathways in diffuse gastric cancer.